Influenza vaccines: present and future.
Palese
Peter
P
Department of Microbiology, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA. peter.palese@mssm.edu
García-Sastre
Adolfo
A
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000998:Antiviral Agents / Q000627:therapeutic use; D003673:Defective Viruses / Q000276:immunology; D006801:Humans; D007252:Influenza Vaccines / Q000494:pharmacology*; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D009975:Orthomyxoviridae / Q000276:immunology; D019444:Vaccines, DNA / Q000494:pharmacology; D015164:Vaccines, Inactivated / Q000494:pharmacology; D014614:Vaccines, Synthetic / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D007252:Influenza Vaccines; D019444:Vaccines, DNA; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic